Llwytho...

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

We have seen a notable increase in the application of PD-1/PD-L1 inhibitors for the treatment of several solid and hematogenous malignancies including metastatic melanoma, non-small-cell lung cancer and lymphoma to name a few. The need for biomarkers for identification of a suitable patient populati...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Biomark Res
Prif Awduron: Diggs, Laurence P., Hsueh, Eddy C.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5353958/
https://ncbi.nlm.nih.gov/pubmed/28331612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-017-0093-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!